Polar Capital Holdings Plc

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 8 securities · passive
Xenon Pharmaceuticals Inc. 13G
XENE · 98420N105
5.2% 11/16/2026
Event 9/30/2026
Savara Inc. 13G
SVRA · 805111101
5.6% 11/16/2026
Event 9/30/2026
Arcutis Biotherapeutics, Inc. 13G
ARQT · 03969K108
5.3% 8/14/2026
Event 6/30/2026
Verastem, Inc. 13G/A
VSTM · 92337C203
4.8% 7/8/2026
Event 3/31/2026
Enliven Therapeutics, Inc. 13G/A
ELVN · 29337E102
8.5% 6/22/2026
Event 3/31/2026
Hagerty, Inc. 13G/A
HGTY · 405166109
5.9% 9/4/2025
Event 6/30/2025
NeuroPace Inc 13G
NPCE · 641288105
9.1% 5/15/2025
Event 3/31/2025
Vtex 13G/A
VTEX · G9470A102
2.8% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.